Sign In
Buy TXG
$31.75
-0.470 (-1.46%)
At Close: Jun 16, 2026
Torex Gold Reports Compelling New Results from the 2024 ELG Underground Drilling Program
06:00pm, Monday, 02'nd Dec 2024
Results continue to indicate impressive grades and ongoing potential to expand resources and replace mined reserves (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(N
Torex Gold Receives Approval for Normal Course Issuer Bid
06:00am, Tuesday, 19'th Nov 2024
Toronto, Ontario--(Newsfile Corp. - November 19, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces that it has received approval from the Toronto Stock Exchange (the "T
Torex Gold Reports Results From The Ongoing 2024 EPO Exploration Program
06:00pm, Wednesday, 13'th Nov 2024
Results indicate strong potential to upgrade Inferred Resources to Indicated Resources and expand resources to the north of the deposit (All amounts expressed in U.S. dollars unless otherwise stated)
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
04:05pm, Thursday, 07'th Nov 2024
PLEASANTON, Calif. , Nov. 7, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in
Torex Gold Reports Q3 2024 Results
06:00pm, Wednesday, 06'th Nov 2024
Solid financial performance and robust cash generation driven by an all-in sustaining costs margin of 52% (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Co
TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative
08:00am, Thursday, 31'st Oct 2024
Cure51 plans to analyze more than 1,000 tumor samples from exceptional cancer survivors PARIS and PLEASANTON, Calif. , Oct. 31, 2024 /PRNewswire/ -- French TechBio startup Cure51 and 10x Genomics,
Torex Gold Provides Q3 2024 Update on Media Luna Project and Increases 2024 Production Guidance
06:00pm, Wednesday, 30'th Oct 2024
Project 87% complete; plant tie-in schedule moves to February; first copper concentrate expected in Q1 (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp.
These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results
02:41pm, Wednesday, 30'th Oct 2024
10x Genomics, Inc. TXG reported a loss for the third quarter on Tuesday.
10x Genomics, Inc. (TXG) Q3 2024 Earnings Call Transcript
08:04pm, Tuesday, 29'th Oct 2024
10x Genomics, Inc. (NASDAQ:TXG ) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Cassie Corneau - Senior Director, Head of Investor Relations and Strategic Finance Se
10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
08:01pm, Tuesday, 29'th Oct 2024
The headline numbers for 10x Genomics (TXG) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street
10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates
06:20pm, Tuesday, 29'th Oct 2024
10x Genomics (TXG) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.51 per share a year ago.
10x Genomics Reports Third Quarter 2024 Financial Results
04:05pm, Tuesday, 29'th Oct 2024
PLEASANTON, Calif. , Oct. 29, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September
Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell
05:05am, Tuesday, 29'th Oct 2024
Medical Systems, 10x Genomics and Omnicell have been highlighted in this Industry Outlook article.
Lower Instruments Sales to Hurt TXG Q3 Earnings, Prelim Sales Down
03:05pm, Monday, 28'th Oct 2024
Per a preliminary report from 10x Genomics, the company's revenues will decline for the third quarter. Lower Instruments sales are likely to have been partially offset by consumable sales growth.
3 Medical Info Systems Stocks to Gain From Healthcare Digitization
01:26pm, Monday, 28'th Oct 2024
Zacks Medical Info Systems industry stocks like Inspire Medical Systems, 10x Genomics and Omnicell are expected to gain from the GenAI wave.
